HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC

Abstract Background In regions with a high prevalence of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, coinfected patients face a heightened risk of developing hepatocellular carcinoma (HCC), termed HBV/HCV-related HCC (HBCV-HCC). We aimed to investigate the contribution of...

Full description

Saved in:
Bibliographic Details
Main Authors: Chiao-Ling Li, Chia-Lang Hsu, You-Yu Lin, Ming-Chih Ho, Rey-Heng Hu, Sheng-Tai Tzeng, Ya-Chun Wang, Yasuhito Tanaka, Pei-Jer Chen, Shiou-Hwei Yeh
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Biomedical Science
Subjects:
Online Access:https://doi.org/10.1186/s12929-024-01094-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559122496978944
author Chiao-Ling Li
Chia-Lang Hsu
You-Yu Lin
Ming-Chih Ho
Rey-Heng Hu
Sheng-Tai Tzeng
Ya-Chun Wang
Yasuhito Tanaka
Pei-Jer Chen
Shiou-Hwei Yeh
author_facet Chiao-Ling Li
Chia-Lang Hsu
You-Yu Lin
Ming-Chih Ho
Rey-Heng Hu
Sheng-Tai Tzeng
Ya-Chun Wang
Yasuhito Tanaka
Pei-Jer Chen
Shiou-Hwei Yeh
author_sort Chiao-Ling Li
collection DOAJ
description Abstract Background In regions with a high prevalence of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, coinfected patients face a heightened risk of developing hepatocellular carcinoma (HCC), termed HBV/HCV-related HCC (HBCV-HCC). We aimed to investigate the contribution of preexisting chronic hepatitis B (CHB) and subsequent chronic hepatitis C (CHC) to the development of HBCV-HCC. Methods We examined HBV’s involvement in 93 HBCV-HCC cases by analyzing HBV DNA integration as an indicator of HCC originating from HBV-infected hepatocytes, compared with 164 HBV-HCCs and 56 HCV-HCCs as controls. Results Next generation sequencing revealed that 55% of HBCV-HCCs exhibited clonal HBV integration, which falls between the rates observed in HBV-HCCs (88%) and HCV-HCCs (7%), with similar integration patterns to HBV-HCCs. Common HCC somatic mutation analysis indicated HCV superinfection in HBCV-HCCs correlated with increased mutation rates in the telomerase reverse transcriptase (TERT) promoter and beta-catenin genes. Transcriptome analysis showed a prevalence of replicating HCV over HBV in HBCV-HCCs, with preexisting HBV exerting a proliferative role. The comparison of clinical characteristics revealed similarities between HBCV-HCC and HCV-HCC patients, including later onset for HBCV-HCC, possibly due to HCV superinfection slowing carcinogenesis. Notably, HBCV-HCCs with the same driver mutation, HBV integration at the TERT promoter, tended to develop later and showed a better prognosis post-tumor resection than HBV-HCCs. Conclusions Our findings shed light on the interplay between preexisting CHB and subsequent CHC in elevating the risk of HBCV-HCC. These insights are crucial for understanding viral etiology-specific carcinogenesis and guiding surveillance policies for HBCV-HCC post-antiviral therapy.
format Article
id doaj-art-1e6a1a03230a4c21aa470e89a7ab64fe
institution Kabale University
issn 1423-0127
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Biomedical Science
spelling doaj-art-1e6a1a03230a4c21aa470e89a7ab64fe2025-01-05T12:42:29ZengBMCJournal of Biomedical Science1423-01272025-01-0132111210.1186/s12929-024-01094-7HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCCChiao-Ling Li0Chia-Lang Hsu1You-Yu Lin2Ming-Chih Ho3Rey-Heng Hu4Sheng-Tai Tzeng5Ya-Chun Wang6Yasuhito Tanaka7Pei-Jer Chen8Shiou-Hwei Yeh9Graduate Institute of Microbiology, National Taiwan University College of MedicineDepartment of Medical Research, National Taiwan University HospitalGraduate Institute of Clinical Medicine, National Taiwan University College of MedicineDepartment of Surgery, National Taiwan University HospitalDepartment of Surgery, National Taiwan University HospitalTCM Biotech International Corp.TCM Biotech International Corp.Department of Gastroenterology and Hepatology, Faculty of Life Sciences, Kumamoto UniversityGraduate Institute of Clinical Medicine, National Taiwan University College of MedicineGraduate Institute of Microbiology, National Taiwan University College of MedicineAbstract Background In regions with a high prevalence of chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, coinfected patients face a heightened risk of developing hepatocellular carcinoma (HCC), termed HBV/HCV-related HCC (HBCV-HCC). We aimed to investigate the contribution of preexisting chronic hepatitis B (CHB) and subsequent chronic hepatitis C (CHC) to the development of HBCV-HCC. Methods We examined HBV’s involvement in 93 HBCV-HCC cases by analyzing HBV DNA integration as an indicator of HCC originating from HBV-infected hepatocytes, compared with 164 HBV-HCCs and 56 HCV-HCCs as controls. Results Next generation sequencing revealed that 55% of HBCV-HCCs exhibited clonal HBV integration, which falls between the rates observed in HBV-HCCs (88%) and HCV-HCCs (7%), with similar integration patterns to HBV-HCCs. Common HCC somatic mutation analysis indicated HCV superinfection in HBCV-HCCs correlated with increased mutation rates in the telomerase reverse transcriptase (TERT) promoter and beta-catenin genes. Transcriptome analysis showed a prevalence of replicating HCV over HBV in HBCV-HCCs, with preexisting HBV exerting a proliferative role. The comparison of clinical characteristics revealed similarities between HBCV-HCC and HCV-HCC patients, including later onset for HBCV-HCC, possibly due to HCV superinfection slowing carcinogenesis. Notably, HBCV-HCCs with the same driver mutation, HBV integration at the TERT promoter, tended to develop later and showed a better prognosis post-tumor resection than HBV-HCCs. Conclusions Our findings shed light on the interplay between preexisting CHB and subsequent CHC in elevating the risk of HBCV-HCC. These insights are crucial for understanding viral etiology-specific carcinogenesis and guiding surveillance policies for HBCV-HCC post-antiviral therapy.https://doi.org/10.1186/s12929-024-01094-7Hepatocellular carcinomaHepatitis B virusHepatitis C virus
spellingShingle Chiao-Ling Li
Chia-Lang Hsu
You-Yu Lin
Ming-Chih Ho
Rey-Heng Hu
Sheng-Tai Tzeng
Ya-Chun Wang
Yasuhito Tanaka
Pei-Jer Chen
Shiou-Hwei Yeh
HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
Journal of Biomedical Science
Hepatocellular carcinoma
Hepatitis B virus
Hepatitis C virus
title HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
title_full HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
title_fullStr HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
title_full_unstemmed HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
title_short HBV DNA integration and somatic mutations in HCC patients with HBV-HCV dual infection reveals profiles intermediate between HBV- and HCV-related HCC
title_sort hbv dna integration and somatic mutations in hcc patients with hbv hcv dual infection reveals profiles intermediate between hbv and hcv related hcc
topic Hepatocellular carcinoma
Hepatitis B virus
Hepatitis C virus
url https://doi.org/10.1186/s12929-024-01094-7
work_keys_str_mv AT chiaolingli hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT chialanghsu hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT youyulin hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT mingchihho hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT reyhenghu hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT shengtaitzeng hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT yachunwang hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT yasuhitotanaka hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT peijerchen hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc
AT shiouhweiyeh hbvdnaintegrationandsomaticmutationsinhccpatientswithhbvhcvdualinfectionrevealsprofilesintermediatebetweenhbvandhcvrelatedhcc